• XVIVO

    Clinically optimised solutions and systems for transplantation

  • XPS™

    The first medical device approved by the US FDA for ex vivo lung perfusion (EVLP) of initially rejected donor lungs

    • Extensive clinical practice, based on expertise and experience from clinicians
    • Developed with daily clinical challenges in mind
    Read more

  • Our vision

    Nobody Should Die Waiting For A New Organ

    Learn More
Learn more about our abdominal product line Click here

  • XVIVO helps transplant surgeons and perfusionists to increase operating room efficiency

  • House

    XVIVO offers transplant centers and clinics a research focused and reliable EVLP-partner

  • Lungs

    XVIVO products facilitate an optimal use of available donor organs

Innovation for transplantation

XVIVO is a medical technology company focused on developing optimized solutions for organ, tissue and cell preservation and perfusion in connection with transplantation. The company is firmly rooted in medical science.

We collaborate with transplant teams to save lives. Our mission is to increase the survival rates of patients awaiting transplantation by supporting transplant teams in every way we can. We join forces with the transplant teams to give more patients a better life. We provide our customers with solutions and systems that can improve the transplant process outcome and expand the pool of transplantable organs.

Our products